Lykos Therapeutics is cutting 75% of staff after FDA rejected its MDMA drug for mental health. The FDA's decision marks the first time the agency considered a psychedelic for medical use. Lykos plans ...
New Study Supports , MDMA's Potential for Improving , Self-Experience in PTSD Patients. PsyPost reports that MDMA-assisted ...
Use of the drug MDMA, commonly known as ecstasy, may lead to lasting difficulties with learning and memory that persist long ...
Lykos Therapeutics, the drug’s manufacturer, said the agency requested an additional phase 3 clinical trial to study the drug’s safety and efficacy, according to an Aug. 9 news release from the ...
The Food and Drug Administration on Friday rejected a California drug company's request to market the psychedelic drug MDMA combined with talk therapy as a treatment for post-traumatic stress disorder ...
The Food and Drug Administration (FDA) this week declined to approve the use of MDMA — popularly known as Ecstasy or Molly — for MDMA-assisted therapy for treating PTSD, disappointing many Americans ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results